Britannia has ~32% market share in biscuits, which we expect to gradually move up by ~100 basis points every year over the next 3-4 years driven by: increasing share in the 'Hindi Belt' led by distribution expansion, launch o
Sun Pharma’s near-term key event is Halol inspection. Halol reinspection in Q4FY18 could unlock several key filings. We increase target price of Sun to Rs 640 (from Rs 595) as we roll forward to FY20, with EPS unchanged.
As Coal India ramps up production, this may reverse. Jewellery and textiles drove the export disappointment: Some decline in jewellery exports was expected, given the import restrictions in the UAE, but the extent was surpris
Bharti reported a 5/8% beat on Ebitda/adjusted net profits, respectively, for the Sep-17 quarter. 60% of Ebitda beat came from Africa (17% higher than estimates), while India mobile Ebitda was 4% ahead.
We recently met with Maruti management and came back quite positive on the near-term outlook with expectations of a strong Q2 as margins improve from Q1 levels on better product mix (higher ASP and lower discounts) and operat